Online survey and patient advisory board for chronic kidney disease patients in Japan - A study of the experiences and perceptions of patients with chronic kidney disease using mixed methods research -

Online survey and patient advisory board for chronic kidney disease patients in Japan - A study of the experiences and perceptions of patients with chronic kidney disease using mixed methods research - - A study of the experiences and perceptions of patients with chronic kidney disease using mixed methods research

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042300

Enrollment

300

Registered

2020-10-30

Start date

2020-10-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria at the time of enrollment in this study will be eligible for this study 1) Patients aged 20 years or older 2) Patients with a diagnosis of CKD 3) Patients who can access the website and complete the survey 4) Patients willing to participate in the Patient Advisory Board to be held at a later date 5) Patients whose consent is obtained from the patient on the website prior to the start of this study

Exclusion criteria

Exclusion criteria: Patients who meet any of the exclusion criteria will not be enrolled in this study 1) Patients on maintenance dialysis (hemodialysis or peritoneal dialysis) or who planed those 2) Patients who have received or planned to receive a kidney transplant

Design outcomes

Primary

Measure	Time frame
1) Information on patient background and CKD patients' experiences and perceptions of the disease and treatment from patient surveys 2) Information about CKD patients' experiences and perceptions of the disease and treatment from the Patient Advisory Board	—

Countries

Japan

Contacts

Public ContactNobutaka Yagi

Nippon Boehringer Ingelheim Co., Ltd. Medicine Division

nobutaka.yagi@boehringer-ingelheim.com03-6417-2043

Outcome results